Home / Germany / Outlook Therapeutics Inc
Outlook Therapeutics Inc
Short position disclosed on June 28, 2024.
0.59% of the capital sold short
1 disclosing funds
1 disclosures on record
US69012T3059 ISIN code
Evolution of the disclosed total
0%0.2%0.4%0.6%
Oct 2025Jan 2026Apr 2026Jul 2026
June 28, 2024 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Bronte Capital Management Pty Ltd | 0.59% | unchanged | June 28, 2024 |
On the other side: the funds that hold Outlook Therapeutics Inc Titelia
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| June 28, 2024 | Bronte Capital Management Pty Ltd | 0.59% | still open |
Other companies sold short in Germany
- TUI AG 9.00% of the capital sold short
- AUTO1 Group SE 7.29% of the capital sold short
- HelloFresh SE 7.00% of the capital sold short
- Hugo Boss AG 6.18% of the capital sold short
- Gerresheimer AG 5.98% of the capital sold short
- Cancom SE 5.46% of the capital sold short
- PVA TePla AG 5.30% of the capital sold short
- Zalando SE 5.22% of the capital sold short
- LANXESS Aktiengesellschaft 5.11% of the capital sold short
- Tamboran Resources Corp. 4.96% of the capital sold short
- Kontron AG 4.94% of the capital sold short
- Aeluma, INC. 4.82% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Outlook Therapeutics Inc, source Bundesanzeiger, data as at June 28, 2024, https://www.quivad.com/action/outlook-therapeutics-inc